Company Profiles

driven by the PitchBook Platform

Kereos

Description

Developer of a nanoscale drug delivery technology designed to deliver therapeutic drug compounds. The company's nanoscale drug delivery technology makes safe and effective delivery of a broad range of drug compounds to a desired target in the body for the treatment of a variety of diseases.

1999

Founded

PRIVATE

Status

11-50

Employees

2ndary - Private

Latest Deal Type

$31.3M

Total Amount Raised

13

Investors

Description

Developer of a nanoscale drug delivery technology designed to deliver therapeutic drug compounds. The company's nanoscale drug delivery technology makes safe and effective delivery of a broad range of drug compounds to a desired target in the body for the treatment of a variety of diseases.

Website:

www.kereos.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Diagnostic Equipment

Other Industries

Biotechnology

Primary Office

4041 Forest Park Avenue Saint Louis, MO 63108United States +1 (314) 633-1879
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Kereos's full profile, request a free trial.

    Kereos Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Kereos Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Kereos Investors (13)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    180 Degree CapitalVenture CapitalMinority000 0000000 0000
    Advantage Capital (St. Louis)Venture CapitalMinority000 0000000 0000
    Alafi Capital CompanyVenture CapitalMinority000 0000000 0000
    Apjohn VenturesVenture CapitalMinority000 0000000 0000
    Brooke Private Equity AssociatesFund of FundsMinority000 0000000 0000
    180 Degree Capital Venture Capital
    Advantage Capital (St. Louis) Venture Capital
    Alafi Capital Company Venture Capital
    Apjohn Ventures Venture Capital
    Brooke Private Equity Associates Fund of Funds

    Kereos Executive Team (2)

    NameTitleBoard
    Seat
    Contact
    Info
    Gregory Lanza Ph.DCo-Founder & Chief Scientific Officer
    John Hefti MDExecutive Vice President
    Gregory Lanza Ph.D Co-Founder & Chief Scientific Officer
    John Hefti MD Executive Vice President

    Kereos Board Members (5)

    NameRepresentingRoleSinceContact
    Info
    Fred Schwarzer JDCharter Life SciencesManaging Partner000 0000
    Gary StevensonMB Venture PartnersCo-Founder & Managing Partner000 0000
    John Rice Ph.DTriathlon Medical VenturesCo-Founder & Managing Partner000 0000
    Michael Loberg Ph.DSelfBoard Member000 0000
    Samuel Wickline MDSelfBoard Member000 0000
    Fred Schwarzer JD Managing Partner Charter Life Sciences
    Gary Stevenson Co-Founder & Managing Partner MB Venture Partners
    John Rice Ph.D Co-Founder & Managing Partner Triathlon Medical Ventures
    Michael Loberg Ph.D Board Member Self
    Samuel Wickline MD Board Member Self
    Request full access to PitchBook